哮喘中的中性粒细胞:益处、弊端与细菌
本文综述中性粒细胞在哮喘气道炎症中的作用。约1/5成人哮喘患者气道中性粒细胞比例增高,此类患者年龄偏大、气道存在潜在致病菌且对经典治疗反应不佳。中性粒细胞功能随年龄变化,不同年龄组可能需要不同治疗策略。
要点
- 约1/5成人哮喘患者气道中性粒细胞比例增高,对经典治疗反应不佳。
- 中性粒细胞功能随年龄变化,不同年龄组可能需要不同治疗策略。
- 儿童哮喘中中性粒细胞与不良疾病特征关联较少。
核心结论
- 成人中性粒细胞主导型哮喘可能反映对年龄相关中性粒细胞杀菌缺陷的不良反应,导致宿主气道细胞 bystander 损伤、黏液高分泌和气道重塑。
研究设计与样本
- 综述,探讨中性粒细胞募集机制、细胞功能随生命过程的变化及其对哮喘管理的意义。
主要发现
- 约1/5成人哮喘患者气道中性粒细胞比例增高,此类患者年龄偏大、气道存在潜在致病菌且对经典治疗反应不佳。
- 中性粒细胞占循环白细胞总数的70%,在炎症和感染挑战中发挥关键防御作用。
- 随年龄增长,中性粒细胞杀菌功能降低、活性氧释放增加、胞外诱捕网产生减少。
- 儿童哮喘中中性粒细胞与不良疾病特征关联较少,可能致病性较低。
临床怎么用
- 目前尚无针对中性粒细胞主导型哮喘的特异性治疗选择,如靶向中性粒细胞的生物制剂。
- 不同年龄组患者可能需要不同的治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Airway inflammation plays a key role in asthma pathogenesis but is heterogeneous in nature. There has been significant scientific discovery with regard to type 2-driven, eosinophil-dominated asthma, with effective therapies ranging from inhaled corticosteroids to novel biologics. However, studies suggest that approximately 1 in 5 adults with asthma have an increased proportion of neutrophils in their airways. These patients tend to be older, have potentially pathogenic airway bacteria and do not respond well to classical therapies. Currently, there are no specific therapeutic options for these patients, such as neutrophil-targeting biologics.Neutrophils comprise 70% of the total circulatory white cells and play a critical defence role during inflammatory and infective challenges. This makes them a problematic target for therapeutics. Furthermore, neutrophil functions change with age, with reduced microbial killing, increased reactive oxygen species release and reduced production of extracellular traps with advancing age. Therefore, different therapeutic strategies may be required for different age groups of patients.The pathogenesis of neutrophil-dominated airway inflammation in adults with asthma may reflect a counterproductive response to the defective neutrophil microbial killing seen with age, resulting in bystander damage to host airway cells and subsequent mucus hypersecretion and airway remodelling. However, in children with asthma, neutrophils are less associated with adverse features of disease, and it is possible that in children, neutrophils are less pathogenic.In this review, we explore the mechanisms of neutrophil recruitment, changes in cellular function across the life course and the implications this may have for asthma management now and in the future. We also describe the prevalence of neutrophilic asthma globally, with a focus on First Nations people of Australia, New Zealand and North America.
引用
- Crisford H, Sapey E, Rogers GB, et al. Neutrophils in asthma: the good, the bad and the bacteria. Thorax. 2021. PMID: 33632765. doi:10.1136/thoraxjnl-2020-215986
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。